Tag: non-alcoholic fatty liver

spot_img

Rezdiffra (resmetirom): FDA Approves First Treatment for Liver Scarring Due to Fatty Liver Disease 

Rezdiffra (resmetirom) has been approved by the FDA of the USA for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with moderate to...

An Update in Understanding of Non-alcoholic Fatty Liver Disease

Study describes a novel mechanism involved in progression of non-alcoholic fatty liver disease and highlights protein Mitofusin 2 as having the potential to be...

Stay in touch:

87,846FansLike
45,152FollowersFollow
1,772FollowersFollow
49SubscribersSubscribe

Newsletter

Don't miss

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...